A
Anna C. Ferrari
Researcher at New York University
Publications - 32
Citations - 5933
Anna C. Ferrari is an academic researcher from New York University. The author has contributed to research in topics: Prostate cancer & LNCaP. The author has an hindex of 16, co-authored 32 publications receiving 5385 citations. Previous affiliations of Anna C. Ferrari include Icahn School of Medicine at Mount Sinai.
Papers
More filters
Journal ArticleDOI
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Philip W. Kantoff,Celestia S. Higano,N. Shore,E. Roy Berger,Eric J. Small,David F. Penson,Charles H. Redfern,Anna C. Ferrari,Robert Dreicer,Robert B. Sims,Yi Xu,Mark W. Frohlich,Paul F. Schellhammer +12 more
TL;DR: The use of sipuleucel-T prolonged overall survival among men with metastatic castration-resistant prostate cancer and immune responses to the immunizing antigen were observed in patients who received sipuleUcel- T.
Journal ArticleDOI
Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer
TL;DR: The PEITC‐mediated cross‐talk between the DNA and chromatin in demethylating and reactivating GSTP1 genes, which is critically inactivated in prostate carcinogenesis, underlines a primary mechanism of cancer chemoprevention.
Journal ArticleDOI
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer
Anthony W. Tolcher,David I. Quinn,Anna C. Ferrari,F. Ahmann,Giuseppe Giaccone,T. Drake,Anne Keating,J.S. de Bono +7 more
TL;DR: YM155 has modest activity in taxane-pretreated CRPC with 25% of patients having prolonged stable disease (≥18 weeks) and the regimen appears to be well tolerated.
Journal ArticleDOI
mTOR Signaling Pathway and mTOR Inhibitors in Cancer Therapy
TL;DR: In this paper, dual PI3K/mTOR kinase inhibitors have been developed with the idea of overcoming resistance to the mTOR inhibition through preventing the activation of PI 3K/Akt as a result of release negative feedback loops.
Journal ArticleDOI
LEF1 in Androgen-Independent Prostate Cancer: Regulation of Androgen Receptor Expression, Prostate Cancer Growth, and Invasion
Yirong Li,L. G. Wang,Miao Zhang,Jonathan Melamed,Xiaomei Liu,Robert E. Reiter,Jian-Jun Wei,Yi Peng,Xuanyi Zou,Angel Pellicer,Michael J. Garabedian,Anna C. Ferrari,Peng Lee +12 more
TL;DR: It is shown that LEF1 overexpression in LNCaP cells resulted in increased AR expression and consequently enhanced growth and invasion ability, whereas LEF 1 knockdown in L NCaP-AI cells decreased ARexpression and, subsequently, growth and invade capacity.